Third Country Participation in JPND
The JPND partner countries recognise that the unmet clinical need and societal impact of ND is a global issue, and that opportunities exist to link to worldwide research efforts in this area.
The policy document below sets out JPND’s approach to working with non-EU Member states/Associated countries, i.e. Third Countries.
Click on the link below to download a copy of the JPND policy.
As of December 2015, the Third Country membership of JPND is composed of:
In 2012, Canada was accepted as the first Third Country member of JPND. In accordance with JPND policy, Canada became a full member in 2014.
On November 9th, 2012, a conference took place to discuss USA accession to JPND. More information on the conference is available here or on the link on the left-hand side of this page.